Canagliflozin‐induced renal glutathione distribution mapping in non‐diabetic male rat kidneys
Physiological Reports · 2025
DOI: 10.14814/phy2.70320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2025. Verfasst von Guy Watanabe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Hypertension, Fukushima Medical University School of Medicine, Fukushima, Japan. Hauptthemen laut MEDLINE: Canagliflozin, Glutathione, Sodium-Glucose Transporter 2 Inhibitors, Kidney. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Canagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, has direct renoprotective effects beyond lowering blood glucose levels. The inhibition of sodium reabsorption via SGLT2 reduces the overload on proximal tubules, thereby suppressing the generation of reactive oxygen species (ROS) and preventing a decline in renal function. To clarify the pharmacological mechanism of SGLT2 inhibitor, we investigated the effects of canagliflozin on oxidative stress in the kidneys of normal, non‐diabetic Sprague–Dawley rats. Screening using mass spectrometry images revealed a significant elevation map of the reduced form of glutathione in the renal cortex of canagliflozin‐treated non‐diabetic rats. These results suggest that canagliflozin reduces oxidative stress through ROS scavenging mechanisms. Considering that ROS play major roles in renal dysfunction regardless of diabetes mellitus, these findings suggest that canagliflozin is applicable to a broader range of renal diseases beyond diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Hypertension, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Department of Diabetes, Endocrinology, and Metabolism, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Department of Hygiene and Preventive Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Faculty of Food and Agricultural Sciences, Fukushima University, Fukushima, Japan.
ORCID-Profile: Shoichiro Horita, Shingen Misaka, Kenju Shimomura
Förderung
- MEXT | Japan Society for the Promotion of Science (JSPS)
- Japan Society for the Promotion of Science
Zitieren
APA
Watanabe, G., Horita, S., Moriya, R. F., Masuishi, Y., Misaka, S., Taira, S., Shimomura, K., Shimabukuro, M., & Kazama, J. J. (2025). Canagliflozin‐induced renal glutathione distribution mapping in non‐diabetic male rat kidneys. Physiological Reports. https://doi.org/10.14814/phy2.70320
Vancouver
Watanabe G, Horita S, Moriya RF, Masuishi Y, Misaka S, Taira S, et al. Canagliflozin‐induced renal glutathione distribution mapping in non‐diabetic male rat kidneys. Physiological Reports. 2025. doi:10.14814/phy2.70320
BibTeX
@article{Watanabe2025,
author = {Watanabe, Guy and Horita, Shoichiro and Moriya, Reika Flora and Masuishi, Yusuke and Misaka, Shingen and Taira, Shu and Shimomura, Kenju and Shimabukuro, Michio and Kazama, Junichiro James},
title = {Canagliflozin‐induced renal glutathione distribution mapping in non‐diabetic male rat kidneys},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70320}
}
EUVIMED